Discover
ABUS
Arbutus Biopharma Corporation
4.73
2 x 3.46
2 x 5.92
bid
ask
-
0.07
1.46%
2 @ 04:23 AM
4.75 +0.02 (0.42%)
| Ytd | -1.66% | |
| 1y | 48.74% |
4.63
day range
4.89
3.08
52 week range
5.10
| Open | 4.82 | Prev Close | 4.80 | Low | 4.63 | High | 4.89 | Mkt Cap | 934.35M |
| Vol | 2.98M | Avg Vol | 1.97M | EPS | 0.83 | P/E | 5.70 | Forward P/E | -9.35 |
| Beta | 1.92 | Short Ratio | 6.50 | Inst. Own | 53.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 4.38 | 200-d Avg | 4.42 | 1yr Est | 5.08 |
| Income Statement | |||
| Total Revenue | 179.13M | ||
| Revenues (USD) | 179.13M | ||
| Gross Profit | 179.13M | ||
| Operating Expenses | 10.01M | ||
| Research and Development Expense | 4.12M | ||
| Selling, General and Administrative Expense | 5.89M | ||
| Operating Income | 169.12M | ||
| Interest Expense | 17.00K | ||
| Net Income | 169.70M | ||
| Net Income Common Stock | 169.70M | ||
| Net Income Common Stock (USD) | 169.70M | ||
| Consolidated Income | 169.70M | ||
| Earnings per Basic Share | 0.88 | ||
| Earnings per Basic Share (USD) | 0.88 | ||
| Earnings per Diluted Share | 0.87 | ||
| Earning Before Interest & Taxes (EBIT) | 169.71M | ||
| Earning Before Interest & Taxes (USD) | 169.71M | ||
| Weighted Average Shares | 193.77M | ||
| Weighted Average Shares Diluted | 195.21M | ||
| Balance Sheet | |||
| Cash and Equivalents | 23.71M | ||
| Cash and Equivalents (USD) | 23.71M | ||
| Investments | 71.52M | ||
| Investments Current | 71.52M | ||
| Trade and Non-Trade Receivables | 1.31M | ||
| Current Assets | 277.01M | ||
| Property, Plant & Equipment Net | 22.00K | ||
| Total Assets | 277.16M | ||
| Debt Current | 631.00K | ||
| Total Debt | 3.91M | ||
| Current Liabilities | 5.11M | ||
| Debt Non-Current | 3.28M | ||
| Total Liabilities | 16.99M | ||
| Accumulated Retained Earnings (Deficit) | -1.21B | ||
| Accumulated Other Comprehensive Income | -48.19M | ||
| Shareholders Equity | 260.18M | ||
| Shareholders Equity (USD) | 260.18M | ||
| Assets Non-Current | 153.00K | ||
| Total Debt (USD) | 3.91M | ||
| Liabilities Non-Current | 11.88M | ||
| Trade and Non-Trade Payables | 4.47M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.00K | ||
| Net Cash Flow from Financing | 11.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.70M | ||
| Issuance (Purchase) of Equity Shares | 11.62M | ||
| Net Cash Flow from Investing | 2.20M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.20M | ||
| Net Cash Flow from Operations | -8.11M | ||
| Effect of Exchange Rate Changes on Cash | -10.00K | ||
| Share Based Compensation | 1.36M | ||